Latest News
From the Journals
Oncology postmarketing requirements mostly on schedule
Postmarketing studies required by the FDA after accelerated approval of oncology drugs tend to be done on time, but drugs often remain on the...
From the Journals
Advanced adenoma on colonoscopy linked to increased colorectal cancer incidence
The incidence of colorectal cancer was 20.0 per 10,000 person-years for advanced adenoma, more than 2 times higher than with nonadvanced or no...
From the Journals
E-cigarette usage has changed
More adults are trying them, but fewer are using them regularly.
Conference Coverage
Design limitations may have compromised DVT intervention trial
WASHINGTON – The preferred evaluation – intravascular ultrasound – was not used.
From the Journals
Is adjuvant chemo warranted in stage I ovarian clear cell carcinoma?
In a retrospective cohort study of 2,325 patients with stage I ovarian clear cell carcinoma, 5-year OS was 89.2% for patients receiving adjuvant...
Feature
White House pushes transparency in drug price plan
American Patients First aims to bring the cost conversation into the exam room, as well as to cut out the middleman in the pharmaceutical economy...
Conference Coverage
Structured PPH management cuts severe hemorrhage
AUSTIN, TEX. – The checklist-driven approach yielded reductions in other morbidity surrogates as well.
Conference Coverage
Children with Down syndrome and ALL have good outcomes today
PITTSBURGH – With better therapy and supportive care, prospects for children with Down syndrome and standard risk ALL have improved in recent...
From the Journals
5-year data show deepening response with ibrutinib in CLL
The long-term findings don’t raise red flags about safety with the drug in CLL.
From the Journals
Breast cancer: More pathogenic variants detected as multiple-gene sequencing takes over
Multiple-gene sequencing has rapidly replaced BRCA1/2-only testing in community practice.
From the Journals
Intravenous antiemetic combination is well tolerated
An intravenous combination of two antiemetic medications is as well tolerated as is the oral version for managing chemotherapy-related nausea and...